Over the last four weeks there were 35,120 casesof COVID in the region. Please note that the actual number of cases is likely to be much more. For further information please go to the latest NSW COVID statistics. Over the last few days there has been an increase in the number of COVID cases in NSW with over 30,000 recorded on Wednesday 16March. Primary care providers should exercise greater vigilance.
Management of COVID vaccines
If your practice has an excess of COVID-19 vaccines, please notify CESPHN (email@example.com) as we may be able to help coordinate a transfer of the stock ideally two week prior to thaw use by date.
You should also notify the Vaccine Operations Centre (VOC) at firstname.lastname@example.org of your excess doses so that they may be able to facilitate transfers outside the CESPHN region. Please note in the email to VOC that you have already contacted CESPHN.
Fourth dose of COVID-19 vaccine
GPs are also encouraged to review their patients and consider eligibility for 4th dose for any that are immunocompromised. The definition of booster doses and eligibility for people with severe immunocompromise is this – a primary course is defined as 3 doses of a COVID-19 vaccine, as recommended by ATAGI for people with severe immunocompromise. For more information: ATAGI recommendations on the use of a booster dose of COVID-19 vaccine
Mask wearing in practices
Healthcare practices are considered to be at high risk of transmission of COVID-19. In addition, they are considered different to general workplace settings due to the potential susceptibility of patients. When a person with COVID-19 attends a practice during their infectious period as a staff member, patient or carer, a risk assessment should be undertaken. Exposures can occur during individual clinical consultations, in group scenarios and whilst in non-clinical settings such as a waiting room.
General practices and their staff should continue to wear masks. It’s also recommended that your patients and anyone visiting your practice wear a mask.
The COVID-19 Vaccination Training Program has released a new additional module for Moderna (6 to 11 years). All immunisation providers must complete the additional age specific training modules. Many of the existing modules have also been updated with new information to reflect the latest ATAGI recommendations.
COVID-19 vaccination rates for children 5-11 years old by LGA
This report, updated 15 March, lists the percentage of people aged between 5-11 years old who have been vaccinated against COVID-19 by local government area. CESPHN is concerned about low vaccination rates in children and general practices are encouraged to identify those families who require vaccination support.
Differences between COVID-19 vaccines
This handy table from the Department of Health provides the key differences between each COVID-19 vaccine approved for use in Australia. It shows vaccine type, approved age, cap colour, dose volume, dilution required, recommended dose interval, approved primary course dose interval, third dose, storage temperature, ATAGI recommended for pre-drawn doses, storage time for open vials and transport limitations.
COVID-19 care in the community
A reminder to check HealthPathways regularly for the latest updates on caring for COVID positive patients in the community. These have been updated to include information on the new oral antiviral treatments.
Some people in our community may not be able to access a GP or vaccination hub to receive a COVID-19 vaccination. The CESPHN Vax at Home Service is ONLY for those people who are housebound and not able to leave their house to receive a COVID-19 vaccination or booster (their carers will also be able to be vaccinated).
The Vax at Home Service will accept referrals for people 16 years and over. For children 12-16 years with special circumstances and may require further support, referrals will be reviewed on a case by case basis.
Patient self-referrals will NOT be accepted. Patients should speak with their GP for a referral to this program if appropriate. Referrals will be accepted from general practitioners and from Local Health Districts.
Referrals MUST be sent through this Vax at Home Service Online Form – for people who are housebound and reside in the Sydney Local Health District or South Eastern Sydney Local Health District regions.
To order PPE for your practice or pharmacy click here. Distribution of pulse oximeters to patients identified as high risk is occurring via local health districts. CESPHN has access to a small supply of pulse oximeters.
Accessing pulse oximeters for your patient
Individual patients – distribution of pulse oximeters to patients identified as high risk is occurring via local health CESPHN have access to a small supply. GPs with patients they believe require a pulse oximeter urgently are asked to complete this CESPHN Pulse Oximeter online formwith the patients details and we will arrange delivery of an oximeter.
General practices – practices actively seeing moderate risk COVID positive patients can also be sent up to five pulse oximeters per practice via email to email@example.com.
Maroubra Medicare Urgent Care Clinic (UCC) is now open The Maroubra Medicare Urgent Care Clinic (UCC) is now open, seven days a week, from 8.00am to 8.00pm. It was officially launched by member for Kingsford Smith, the hon Matt Thistlethwaite MP (pictured at the launch with CESPHN CEO Nathalie Hansen…
Media Release: Central and Eastern Sydney PHN releases Healthy Ageing Strategy to empower older people In response to the increasing longevity and rapid growth of the older population the Central and Eastern Sydney Primary Health Network (CESPHN) is proud to release its new Healthy Ageing Strategy 2023-2028. This comprehensive strategy…
Immunisation Weekly Update: Are your vaccines ready for summer? In the summer season, storms are more likely to occur, which can lead to power outages. Refer to the Cold Chain Toolkit to ensure all vaccination storage requirements are in place should an outage occur. Disposal of Zostavax® Zostavax® vaccine will…
Immunisation Weekly Update: COVID-19 XBB.1.5 vaccine onboarding The Australian Government has accepted the latest advice from ATAGI on the use of the new COVID-19 XBB 1.5 vaccine as part of the National COVID-19 Vaccine Program. All sites currently participating in the COVID-19 Vaccination Program will be onboarded for the three…
Immunisation Weekly Update: Increase in COVID-19 infection cases ATAGI notes a recent increase in COVID-19 cases since November 2023 across Australia and encourages all eligible people who have not yet had their recommended 2023 COVID-19 vaccine dose/s to receive them as soon as possible. A first 2023 dose is recommended…
Immunisation Weekly Update: Vaccination coverage in RACF Australian Immunisation Register (AIR) data suggests that only 36% of people aged 70+ living in the central and eastern Sydney PHN region are immunised against Pneumococcal diseases. Immunisation providers are reminded to check AIR immunisation history statements of patients going into Residential Aged…
Immunisation Weekly Update: Introduction of Shingrix® to the NIP From 1 November 2023, the shingles vaccine Shingrix® will replace Zostavax® on the National Immunisation Program (NIP) schedule for the prevention of shingles and post-herpetic neuralgia. It will be available for eligible people most at risk of complications from shingles. A…
NSW urged to prepare for heat wave Severe heatwave conditions are forecast in NSW in the coming days. Please read the NSW Health media release about taking steps to prevent heat-related illness. For further information about staying safe in a heatwave, visit Beat the heat and stay well during hot…